Limba
Romanian
Romanian
English|
Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptoragonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).
| Price | 1.658,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptoragonist with the potential for the treatment of type 2 diabetes mellitus (T2DM). |
